ArticleMolecular therapy. Methods & clinical development2024

A self-complementary AAV proviral plasmid that reduces cross-packaging and ITR promoter activity in AAV vector preparations.

Noah K Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.